Metronidazole
- Generic Name
- Metronidazole
- Brand Names
- Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
- Drug Type
- Small Molecule
- Chemical Formula
- C6H9N3O3
- CAS Number
- 443-48-1
- Unique Ingredient Identifier
- 140QMO216E
- Background
Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it ...
- Indication
Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, t...
- Associated Conditions
- Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
- Associated Therapies
- -
Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 170
- Registration Number
- NCT05135182
- Locations
- 🇨🇳
Qilu hosipital, Jinan, Shandong, China
Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 106
- Registration Number
- NCT05129176
- Locations
- 🇨🇳
Qilu hospital, Jinan, Shandong, China
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
- Conditions
- Interventions
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Hospital da Senhora da Oliveira
- Target Recruit Count
- 100
- Registration Number
- NCT05100446
- Locations
- 🇵🇹
Vítor Bruno Macedo da Silva, Guimarães, Portugal
Helicobacter Pylori Eradication and Follow-up
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 4447
- Registration Number
- NCT05061732
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 1300
- Registration Number
- NCT05049902
- Locations
- 🇨🇳
Maternity and Child Care Health Center of Dezhou, Dezhou, Shandong, China
🇨🇳Heze Municipal 3rd people's hospital, Heze, Shandong, China
🇨🇳Qilu hosipital, Jinan, Shandong, China
Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 504
- Registration Number
- NCT05023577
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Tetracycline Versus Doxycycline for HP Rescue Therapy
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 242
- Registration Number
- NCT05018923
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
PPI-amoxicillin for H. Pylori Treatment
- Conditions
- Interventions
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 732
- Registration Number
- NCT05014685
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Ari M Grinspan
- Target Recruit Count
- 4
- Registration Number
- NCT04968951
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
- Conditions
- Interventions
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT04927312
- Locations
- 🇯🇵
Saiseikai Maebashi Hospital, Maebashi, Gunma, Japan
🇯🇵Yamagata City Hospital Saiseikan, Yamagata, Japan
🇯🇵National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.